PTC is committed to bringing hope to patients with rare and genetic diseases.
Our scientists are finding new ways to regulate biology to control disease.
We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases.
About PTC Clinical Trials Careers at PTC PTC STRIVE Awards Program
PTC Therapeutics Reports Second Quarter 2015 Financial Results And Provides Corporate Update
PTC Therapeutics To Host Conference Call To Discuss Second Quarter 2015 Financial Results
PTC Therapeutics' Ceo Stuart W. Peltz, Ph.d. Finalist For The 2015 Njbiz Innovation Hero Award
View all latest news